BrainsWay Ltd.
OTC: BRSYF0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Hadar Levy
- Employees
- 120
- Headquarters
- Jerusalem, Israel
- IPO year
- 2011
- Market cap
- $675.8M
- Website
- https://www.brainsway.com
Loading BRSYF…
Loading profile data…Frequently asked questions about BRSYF
What does BrainsWay Ltd. (BRSYF) do?
BrainsWay Ltd. is a global medical technology company focused on innovating and providing non-invasive neurostimulation therapies for a broad spectrum of mental health and neurological conditions. Operating across the United States, Europe, Israel, and other international markets, the company's core offering is its Deep Transcranial Magnetic Sti...
Where does BRSYF trade?
BrainsWay Ltd. (BRSYF) trades on the Other OTC.
What sector is BRSYF in?
BrainsWay Ltd. (BRSYF) operates in the Healthcare sector, specifically in the Medical - Devices industry.
Who is the CEO of BrainsWay Ltd.?
Hadar Levy is the chief executive officer of BrainsWay Ltd. (BRSYF).
Where is BrainsWay Ltd. headquartered?
BrainsWay Ltd. is headquartered in Israel.
Does BRSYF pay a dividend?
BrainsWay Ltd. (BRSYF) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did BRSYF go public?
BrainsWay Ltd. (BRSYF) completed its initial public offering in 2011.